World Tuberculosis Day 2020

Expert-driven In Silico Drug Discovery Solutions
23 March 2020
Andrew Golub
Group Leader, Molecular Design

Tuberculosis (TB) is an infection caused by slow-growing bacteria called Mycobacterium tuberculosis. TB most often affects the lungs, and, despite quite a popular opinion that it is a disease of the past, it continues to be a significant threat to global public health. TB can progress and even be fatal if it is not treated properly. One-quarter of the world's population (about 1.4 billion people) are infected with TB. Most infected people are protected by their immune system from becoming sick despite having the tuberculosis germs in their bodies (so-called “latent TB”). However, about 10 million people have active TB disease worldwide. TB is much less common in the United States, nevertheless, it continues to cause disproportionate illness in some populations. Among even greater challenges there are forms of TB that are drug-resistant or multi-drug resistant. This implies that TB germs in the body are not affected by some of the drugs used to treat the infection.

Each year, we commemorate World Tuberculosis (TB) Day on March 24 to raise public awareness about disastrous health, social and economic consequences of TB, and to step up efforts to end the global TB epidemic. The date marks the day in 1882 when Dr. Robert Koch announced that he had discovered the bacterium that causes TB, which opened the way towards diagnosing and curing this disease. The theme of World TB Day 2020 - ‘It’s Time’ – puts the emphasis on the urgency to act on accelerating the TB response and ensuring access to care, elimination of stigma and sustainable financing (including appropriate research funding).

Joining efforts with our partners and colleagues around the world, Life Chemicals raises awareness of the stumbling blocks that hinder the progress toward the elimination of this devastating disease. To make a practical contribution to the World Tuberculosis Day activities worldwide, our Company is offering a number of focused libraries for tuberculosis research and drug discovery:

These libraries are prepared specifically for HTS screening as dry powders or DMSO solutions. Compound cherry-picking and customer-tailored selection are available. For details, please, contact us at orders@lifechemicals.com and visit our website for more information. The sdf files with compound structures from the Libraries described above can be downloaded from the Downloads section.

23 March 2020, 12:18 Andrew Golub Computational Chemistry

Comments ()